Chief Operating Officer
François graduated with an MD from Geneva Medical School and obtained a master in medical statistics from the London School of Hygiene and Tropical Medicine. He also has an MBA from Warwick Business School. After several years in academia, he joined Swissmedic, the Swiss medicines agency where he was responsible for the registration and market surveillance of neuropsychiatric drugs. He then joined Serono SA, now Merck Serono, where he worked in clinical and business development. François was the CEO of GeNeuro from 2009 to 2015.
Medical statistics, Neuropsychiatric drugs,clinical and business development